Economy

Exelixis cancer drug meets key goal in late-stage trial

Exelixis cancer drug meets key goal in late-stage trial”

The primary endpoint was overall survival.

According to the release, the FDA determined the company's supplemental New Drug Application (sNDA) for CaboMetyx (cabozantinib) for patients with previously untreated advanced renal cell carcinoma (RCC) to be sufficiently complete to permit a substantive review.

French drugmaker Ipsen and its USA partner Exelixis have announced that the CELESTIAL trial met its primary endpoint of overall survival (OS), with cabozantinib providing a statistically significant and clinically meaningful improvement in median OS compared to placebo in patients with advanced hepatocellular carcinoma (HCC).

Hepatocellular carcinoma is the most common form of kidney cancer causing pain in the abdomen area. It made up three-fourths of the almost 41,000 cases that will be diagnosed in 2017 in the U.S. Interim looks at data often have higher thresholds for success than the final readouts, so there's a good chance that the data will look pretty good, but investors will have to wait for a medical conference where Exelixis will present the data to find out.

Sales in liver cancer could come even earlier since Cabometyx is already on the market as a second-line kidney cancer treatment.

After the successful clinical trial, the drug is now moved up to priority review by the FDA.

The FDA granted Priority Review of the filing and assigned a Prescription Drug User Fee Act (PDUFA) action date for February 2018.



Like this

Latest


17 October 2017
Trump comments on Green Beret deaths, knocks Obama
President Donald Trump accused President Barack Obama of failing to call the families of fallen soldiers. When pressed by a reporter, Trump backed away from his initial claim that Obama did not place calls.

16 October 2017
Boost for England and Liverpool as Adam Lallana's return date revealed
Liverpool midfielder Adam Lallana is expected to make his return to action after the November global break, the Mirror have reported.

16 October 2017
Domino's Pizza's (NYSE:DPZ) Neutral Rating Reiterated at Instinet
Insiders contain to comply with strict disclosure requirements with regard to the sale or purchase of the shares of their company. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return.

16 October 2017
New Resident Evil 7 Trailer Shows More Footage of Upcoming DLC
Join Chris Redfield as he hunts down Lucas Baker in Not a Hero , taking place after the events of Resident Evil 7 biohazard . In End of Zoe , a man named Joe ends up finding Zoe Baker and offering her aid during what appears to be a dire situation.

16 October 2017
Avengers 4 Casting Call Hints At Death Scene
But now there may be a film on the horizon that focuses on all of the prominent women characters in the MCU, not just Black Widow .

16 October 2017
Analyst Buzz: Sanchez Energy Corporation (SN)
ValuEngine lowered EP Energy Corporation from a hold rating to a sell rating in a research note on Monday, October 2nd. Following the acquisition, the director now directly owns 547,358 shares in the company, valued at $2,249,641.38.

16 October 2017
Chelsea stunned, City in seven heaven
Meanwhile, Crystal Palace picked up their first points of the season with a shock win over Champions Chelsea at Selhurst Park. The Argentina striker stayed on the bench on his return to the squad after sustaining a broken rib in a vehicle crash.

16 October 2017
American Express Company (NYSE:AXP) Insider Sells $926326.50 in Stock
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by TrueBlueTribune and is the property of of TrueBlueTribune. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink .

16 October 2017
Bessemer Group Inc. Sells 25793 Shares of Coca-Cola Company (The) (KO)
The company reported $0.59 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.57 by $0.02. For KO, the company now has $11.72 Billion of cash on the books, which is offset by $17.83 Billion current liabilities.

16 October 2017
Stranger Things Season 2 Video Answers A Huge Question About Eleven's Return
There's a telltale trickle of blood emanating from her nose indicating the use of her mind powers. The new trailer for the second season of "Stranger Things" was released Friday - the 13th.



Recommended